Online inquiry

IVTScrip™ mRNA-Human AIM1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK15933MR)

This product GTTS-WK15933MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AIM1 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001371242.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 202
UniProt ID Q9Y4K1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AIM1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK15933MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK11374MR IVTScrip™ mRNA-Human ADTRP, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADTRP
GTTS-WK13162MR IVTScrip™ mRNA-Human ADORA3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADORA3
GTTS-WK9210MR IVTScrip™ mRNA-Human ADAP1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAP1
GTTS-WK11573MR IVTScrip™ mRNA-Human ACTR3B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACTR3B
GTTS-WK7430MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK13180MR IVTScrip™ mRNA-Human AFAP1L2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AFAP1L2
GTTS-WK1727MR IVTScrip™ mRNA-Human CD24, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD24
GTTS-WK17035MR IVTScrip™ mRNA-Human ANKRD66, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD66
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW